267 related articles for article (PubMed ID: 27571579)
1. TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.
Rashedi I; Gómez-Aristizábal A; Wang XH; Viswanathan S; Keating A
Stem Cells; 2017 Jan; 35(1):265-275. PubMed ID: 27571579
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
3. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis.
Li Y; Huang L; Cai Z; Deng W; Wang P; Su H; Wu Y; Shen H
Stem Cells Dev; 2019 Oct; 28(20):1398-1412. PubMed ID: 31456484
[TBL] [Abstract][Full Text] [Related]
4. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
[TBL] [Abstract][Full Text] [Related]
5. The role of Toll-like receptor 3 and 4 in regulating the function of mesenchymal stem cells isolated from umbilical cord.
Zhang L; Liu D; Pu D; Wang Y; Li L; He Y; Li Y; Li L; Qiu Z; Zhao S; Li W
Int J Mol Med; 2015 Apr; 35(4):1003-10. PubMed ID: 25695694
[TBL] [Abstract][Full Text] [Related]
6. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
[TBL] [Abstract][Full Text] [Related]
7. TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway.
Qiu Y; Guo J; Mao R; Chao K; Chen BL; He Y; Zeng ZR; Zhang SH; Chen MH
Mucosal Immunol; 2017 May; 10(3):727-742. PubMed ID: 27649928
[TBL] [Abstract][Full Text] [Related]
8. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells.
Chen D; Ma F; Xu S; Yang S; Chen F; Rong L; Chi Y; Zhao Q; Lu S; Han Z; Pang A; Han Z
Cytotherapy; 2013 Apr; 15(4):423-33. PubMed ID: 23352460
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles.
Hwang S; Sung DK; Kim YE; Yang M; Ahn SY; Sung SI; Chang YS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003458
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists.
Chen X; Zhang ZY; Zhou H; Zhou GW
Dev Growth Differ; 2014 Apr; 56(3):233-44. PubMed ID: 24645700
[TBL] [Abstract][Full Text] [Related]
12. Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation.
Ryu JH; Park M; Kim BK; Ryu KH; Woo SY
Cytokine; 2015 Jun; 73(2):225-35. PubMed ID: 25794662
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F
Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200
[TBL] [Abstract][Full Text] [Related]
14. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
[TBL] [Abstract][Full Text] [Related]
15. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.
Zhao X; Liu D; Gong W; Zhao G; Liu L; Yang L; Hou Y
Stem Cells; 2014 Feb; 32(2):521-33. PubMed ID: 24105952
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
18. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Dysfunction Switches Mesenchymal Stromal Cells Toward an Inflammatory Phenotype and Impairs Their Reparative Properties Via Toll-Like Receptor-4.
Naftali-Shani N; Levin-Kotler LP; Palevski D; Amit U; Kain D; Landa N; Hochhauser E; Leor J
Circulation; 2017 Jun; 135(23):2271-2287. PubMed ID: 28356441
[TBL] [Abstract][Full Text] [Related]
20. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
